Higher Mast Cell Accumulation in Human Adipose Tissues Defines Clinically Favorable Obesity Sub-Phenotypes
Authors:
- Nir GoldsteinNGNir Goldstein
- Yarden KezerleYKYarden Kezerle
- Yftach GepnerYGYftach Gepner
- Yulia HaimYHYulia Haim
- Tal PechtTPTal Pecht
- Roi GazitRoi Gazit
- Vera PolischukVPVera Polischuk
- Idit F. LibertyILIdit F. Liberty
- Boris KirshteinBKBoris Kirshtein
- Ruthy Shaco-LevyRSRuthy Shaco-Levy
- Matthias BlüherMBMatthias Blüher
- Assaf RudichARAssaf Rudich
Open Access
Abstract
The identification of human obesity sub-types may improve the clinical management of patients with obesity and uncover previously unrecognized obesity mechanisms. Here, we hypothesized that adipose tissue (AT) mast cells (MC) estimation could be a mark for human obesity sub-phenotyping beyond current clinical-based stratifications, both cross-sectionally and prospectively. We estimated MC accumulation using immunohistochemistry and gene expression in abdominal visceral AT (VAT) and subcutaneous (SAT) in a human cohort of 65 persons with obesity who underwent elective abdominal (mainly bariatric) surgery, and we validated key results in two clinically similar, independent cohorts (n = 33, n = 56). AT-MC were readily detectable by immunostaining for either c-kit or tryptase and by assessing the gene expression of KIT (KIT Proto-Oncogene, Receptor Tyrosine Kinase), TPSB2 (tryptase beta 2), and CMA1 (chymase 1). Participants were characterized as VAT-MClow if the expression of both CMA1 and TPSB2 was below the median. Higher expressers of MC genes (MChigh) were metabolically healthier (lower fasting glucose and glycated hemoglobin, with higher pancreatic beta cell reserve (HOMA-β), and lower triglycerides and alkaline-phosphatase) than people with low expression (MClow). Prospectively, higher MC accumulation in VAT or SAT obtained during surgery predicted greater postoperative weight-loss response to bariatric surgery. Jointly, high AT-MC accumulation may be used to clinically define obesity sub-phenotypes, which are associated with a “healthier” cardiometabolic risk profile and a better weight-loss response to bariatric surgery.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (209933838 – SFB 1052)
This publication has 35 references indexed in Scilit:
- Mast Cells in Human Adipose Tissue: Link with Morbid Obesity, Inflammatory Status, and DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2012
- Mast cells, angiogenesis, and tumour growthBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2American Journal of Physiology-Cell Physiology, 2011
- Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in miceJournal of Lipid Research, 2011
- Fibrosis in Human Adipose Tissue: Composition, Distribution, and Link With Lipid Metabolism and Fat Mass LossDiabetes, 2010
- Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in miceNature Medicine, 2009
- Gene Expression Profiling of Human Mast Cell Subtypes: An In Silico StudyAllergology International, 2006
- Use and Abuse of HOMA ModelingDiabetes Care, 2004
- Mast cells and angiogenesisAPMIS, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001